YD Bio Ltd SEC filings YDES
YD Bio Ltd has 80 filings in SEC EDGAR's recent list, going back to Feb 14, 2024. Its latest annual report, Form 20-F, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 1, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 6, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Oct 6, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Sep 16, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Sep 10, 2026 | Sep 9, 2026 |
| 4 | Insider transaction | Sep 8, 2026 | Sep 4, 2026 |
| 424B3 | Prospectus | Sep 1, 2026 | — |
| 6-K | Current report (foreign issuer) | Sep 1, 2026 | Jun 30, 2026 |
| 424B3 | Prospectus | Aug 11, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 11, 2026 | Aug 11, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 30, 2026 |
| EFFECT | Filing | May 29, 2026 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | May 26, 2026 | — |
| 6-K | Current report (foreign issuer) | May 1, 2026 | Apr 30, 2026 |
| 20-F | Annual report (foreign issuer) | Apr 30, 2026 | Dec 31, 2025 |
| 3/A | Filing | Apr 20, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 3 | Initial insider ownership | Apr 2, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 2, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 30, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 27, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 26, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 424B3 | Prospectus | Feb 27, 2026 | — |
| 6-K | Current report (foreign issuer) | Feb 26, 2026 | Feb 26, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 424B3 | Prospectus | Feb 5, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 30, 2026 | Jan 30, 2026 |
| 6-K | Current report (foreign issuer) | Jan 21, 2026 | Jan 21, 2026 |
| 6-K | Current report (foreign issuer) | Jan 16, 2026 | Jan 16, 2026 |
| 6-K | Current report (foreign issuer) | Jan 15, 2026 | Jan 15, 2026 |
| 6-K | Current report (foreign issuer) | Jan 6, 2026 | Jan 6, 2026 |
| S-8 | Employee stock plan registration | Jan 2, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 16, 2025 | — |
| 424B3 | Prospectus | Nov 17, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 17, 2025 | Nov 17, 2025 |
| F-1/A | Amendment no. 1 to form f-1 | Oct 24, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 30, 2025 | Jun 30, 2025 |
| UPLOAD | Letter from the SEC | Sep 29, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 26, 2025 | Sep 26, 2025 |
| F-1 | Registration statement (foreign issuer) | Sep 23, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 19, 2025 | Sep 19, 2025 |
| 20FR12B | Registration statement | Sep 5, 2025 | — |
| CERT | Filing | Aug 28, 2025 | — |
| 8-A12B | For registration of certain classes | Aug 20, 2025 | — |
| 6-K | Current report (foreign issuer) | Aug 15, 2025 | Aug 15, 2025 |
| EFFECT | Filing | Jul 18, 2025 | — |
| 424B3 | Prospectus | Jul 18, 2025 | — |
| CORRESP | Letter to the SEC | Jul 16, 2025 | — |
| F-4/A | Registration statement | Jul 16, 2025 | — |
| CORRESP | Letter to the SEC | Jul 10, 2025 | — |
| F-4/A | Registration statement | Jul 10, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 9, 2025 | — |
| CORRESP | Letter to the SEC | Jul 7, 2025 | — |
| F-4/A | Registration statement | Jul 7, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 3, 2025 | — |
| CORRESP | Letter to the SEC | Jun 30, 2025 | — |
| F-4/A | Registration statement | Jun 30, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 18, 2025 | — |
| F-4/A | Registration statement | Jun 5, 2025 | — |
| CORRESP | Letter to the SEC | Jun 4, 2025 | — |
| UPLOAD | Letter from the SEC | May 15, 2025 | — |
| CORRESP | Letter to the SEC | Apr 30, 2025 | — |
| F-4/A | Registration statement | Apr 30, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2025 | — |
| CORRESP | Letter to the SEC | Mar 17, 2025 | — |
| F-4/A | Registration statement | Mar 17, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 14, 2025 | — |
| F-4/A | Registration statement | Jan 30, 2025 | — |
| CORRESP | Letter to the SEC | Jan 29, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2025 | — |
| SEC STAFF ACTION | Filing | Jan 13, 2025 | — |
| F-4/A | Registration statement | Dec 20, 2024 | — |
| F-4/A | Registration statement | Dec 17, 2024 | — |
| F-4 | Registration statement | Nov 25, 2024 | — |
| 425 | Form 425 | Jun 21, 2024 | — |
| 425 | Form 425 | Mar 21, 2024 | — |
| 425 | Form 425 | Mar 15, 2024 | — |
| S-4 | Registration for a merger or exchange | Feb 14, 2024 | — |
Showing 80 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- YDES (Nasdaq), YDESW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Taipei City
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 2011674
- Former names
- True Velocity, Inc./DE (until Jun 21, 2024)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.